Tocilizumab Shortage Prompts US FDA To Loosen CAR-T REMS Requirements

 
• By Brenda Sandburg
  
Tocilizumab
US FDA modifies REMS mandating tocilizumab availability for CAR-T cell treatment • Source: Alamy
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Drug Safety

More from Pink Sheet